Amanote Research
Register
Sign In
Pazolimus: Pazopanib Plus Sirolimus Following Progression on Pazopanib, a Retrospective Case Series Analysis
BMC Cancer
- United Kingdom
doi 10.1186/s12885-016-2618-1
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Genetics
Date
August 8, 2016
Authors
D. Katz
Y. Azraq
F. Eleyan
S. Gill
T. Peretz
O. Merimsky
Publisher
Springer Science and Business Media LLC
Related search
Temozolomide Post Pazopanib Treatment Failure in Patients With Advanced Sarcoma: A Case Series
PLoS ONE
Multidisciplinary
Pazopanib-Induced Asymptomatic Radiological Acute Pancreatitis: A Case Report
Molecular and Clinical Oncology
Cancer Research
Oncology
A Retinal Tear Induced by Pazopanib Therapy: A Case Report
The Medicine Forum
Pulmonary Carcinosarcoma Showing an Obvious Response to Pazopanib: A Case Report
BMC Pulmonary Medicine
Pulmonary
Respiratory Medicine
Pazopanib-Induced Alopecia, an Underestimated Toxicity?
Frontiers in Oncology
Cancer Research
Oncology
Process-Related Impurities of Pazopanib
Pazopanib: A Novel Treatment Option for Aggressive Fibromatosis
Clinical Sarcoma Research
Oncology
Pazopanib in Relapsed Osteosarcoma Patients: Report on 15 Cases
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology